Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
502.31
-1.19 (-0.24%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
77
78
Next >
Vertex Pharma Stock’s Retail Buzz Intensifies As 2025 Revenue View Lift Fails To Offset Q1 Miss
↗
May 05, 2025
The company’s Q1 revenue missed expectations, but the company raised its 2025 revenue guidance, reflecting optimism about growth drivers like cystic fibrosis treatments and its expanding pipeline.
Via
Stocktwits
Topics
World Trade
Monday's after hours session: top gainers and losers in the S&P500 index
↗
May 05, 2025
Let's have a look at what is happening on the US markets after the closing bell on Monday. Below you can find the top S&P500 gainers and losers in today's after hours session.
Via
Chartmill
Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance
↗
May 05, 2025
Vertex Pharmaceuticals reports first-quarter financial results after the market close on Monday. Here's a look at the key highlights from the period.
Via
Benzinga
Vertex Pharmaceuticals (NASDAQ:VRTX) Reports Sales Below Analyst Estimates In Q1 Earnings
May 05, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 3% year on year to $2.77 billion. The company’s full-year revenue guidance of...
Via
StockStory
Earnings Scheduled For May 5, 2025
↗
May 05, 2025
Via
Benzinga
Earnings Outlook For Vertex Pharmaceuticals
↗
May 02, 2025
Via
Benzinga
Vertex Reports First Quarter 2025 Financial Results
May 05, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Vertex Has Lost Some Sizzle Into Q1 Earnings - Can Alyftrek, Journavx Reignite The Momentum?
↗
May 05, 2025
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) reports Q1 earnings with $4.32 EPS and $2.85B revenue. Stock up 25.48% in past year, charts show bullish trend.
Via
Benzinga
Stocks Pause Gains As Treasury Yields Rise: What's Driving Markets Monday?
↗
May 05, 2025
Wall Street kicked off the week with a cautious tone, as major stock indices hovered near the flatline by midday in New York. Investors digested fresh signs of inflationary pressure in the services...
Via
Benzinga
Vertex Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
↗
May 05, 2025
Via
Benzinga
Stock Market Selloff: 4 No-Brainer Stocks to Buy Right Now
↗
May 05, 2025
Now may be a smart time to buy small stakes in these fundamentally robust companies.
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
3 No-Brainer Stocks to Buy in May
↗
May 05, 2025
Via
The Motley Fool
5 Growth Stocks to Buy in May and Go Away
↗
May 04, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
World Trade
Earnings To Watch: Vertex Pharmaceuticals (VRTX) Reports Q1 Results Tomorrow
May 04, 2025
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.
Via
StockStory
Topics
Artificial Intelligence
S&P Global, Berkshire Hathaway, CME Group And A Health Care Stock: CNBC's 'Final Trades'
↗
May 01, 2025
Via
Benzinga
Topics
Stocks
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential
↗
April 30, 2025
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Shows Strong Technical Breakout Potential
Via
Chartmill
These 3 Funds Offer Sky-High Yields of 15% or More and Trade at a Discount
↗
April 30, 2025
Via
The Motley Fool
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
↗
April 29, 2025
Via
Benzinga
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
↗
April 28, 2025
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
My 5 Top Stocks to Buy Right Now in This Highly Volatile Market
↗
April 28, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Energy
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
↗
April 22, 2025
Via
The Motley Fool
3 Relatively Safe Healthcare Growth Stocks You Can Buy and Hold
↗
April 22, 2025
Via
The Motley Fool
Topics
Government
Expert Outlook: Vertex Pharmaceuticals Through The Eyes Of 18 Analysts
↗
April 22, 2025
Via
Benzinga
Fed Chairman Jerome Powell Warns Trump's Tariffs Could Cause Stagflation: 3 Stocks to Buy and Hold if He's Right
↗
April 22, 2025
Via
The Motley Fool
Topics
Economy
Government
World Trade
Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely
↗
April 21, 2025
Vertex Pharmaceuticals is expected to report first quarter earnings on May 5, with investor focus on its two big launches and potential upside surprises.
Via
Benzinga
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
↗
April 18, 2025
Via
The Motley Fool
Topics
Government
World Trade
Peering Into Vertex Pharmaceuticals's Recent Short Interest
↗
April 17, 2025
Via
Benzinga
As The Nasdaq 100 Index Crashes, Is It Safe To Buy The Dip?
↗
April 17, 2025
The Nasdaq 100 Index remains under pressure after forming a death cross pattern a few weeks ago. It has retreated to $18,257, down by over 17.8% from its highest point this year.
Via
Talk Markets
Topics
Stocks / Equities
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
↗
April 16, 2025
Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...
Via
Benzinga
Topics
Government
Stock Market Whiplash: 3 Growth Stocks That Are No-Brainer Buys on the Bounce
↗
April 15, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Government
< Previous
1
2
...
14
15
16
17
18
19
20
21
22
...
77
78
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
